tiprankstipranks
Trending News
More News >
Halozyme’s Strategic Positioning and Market Potential Drive Buy Rating
PremiumRatingsHalozyme’s Strategic Positioning and Market Potential Drive Buy Rating
1M ago
Halozyme announces EC approval of Bristol Myers’ Opdivo developed with Enhanze
Premium
The Fly
Halozyme announces EC approval of Bristol Myers’ Opdivo developed with Enhanze
1M ago
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
Premium
Ratings
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
2M ago
Coinbase, Caterpillar upgraded: Wall Street’s top analyst calls
PremiumThe FlyCoinbase, Caterpillar upgraded: Wall Street’s top analyst calls
2M ago
Halozyme downgraded to Underperform from Market Perform at Leerink
Premium
The Fly
Halozyme downgraded to Underperform from Market Perform at Leerink
2M ago
Cautious Optimism for Halozyme Amid Uncertainties: Hold Rating Maintained
Premium
Ratings
Cautious Optimism for Halozyme Amid Uncertainties: Hold Rating Maintained
2M ago
Halozyme Therapeutics Reports Strong Q1 2025 Results
PremiumCompany AnnouncementsHalozyme Therapeutics Reports Strong Q1 2025 Results
2M ago
Halozyme’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
Premium
Ratings
Halozyme’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
2M ago
Closing Bell Movers: Sarepta falls 21% after earnings and guidance cut
Premium
The Fly
Closing Bell Movers: Sarepta falls 21% after earnings and guidance cut
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100